Is this you? Create Your Porfile
Avatar

Martin De La Nava Eva Maria

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Martin De La Nava Eva Maria is active.

Explore More

Publication

Featured researches published by Martin De La Nava Eva Maria.

Archive | 2016

ΑΝΑΣΤΟΛΕΙΣ ΠΡΩΤΕΪΝΙΚΩΝ ΚΙΝΑΣΩΝ

Coates David Andrew; De Dios Alfonso; De Prado Gonzales Ana; Del Prado Catalina Miriam Filadelfa; Garcia Paredes Maria Cristina; Gelbert Lawrence Mark; Knobeloch John Monte; Martin De La Nava Eva Maria; Martin Ortega Finger Maria Dolores; Martinez Perez Jose Antonio; Mateo Herranz Ana Isabel; Perez Martinez Carlos; Sanchez-Martinez Concepcion

Archive | 2015

ΕΝΩΣΕΙΣ ΚΑΙ ΜΕΘΟΔΟΙ ΓΙΑ ΤΗ ΘΕΡΑΠΕΙΑ ΔΥΣΛΙΠΙΔΑΙΜΙΑΣ

Chen Xinchao; Cioffi Christopher Lawrence; Dinn Sean Richard; Escribano Ana Maria; Fernandez Maria Carmen; Fields Todd; Herr Robert Jason; Mantlo Nathan Bryan; Martin De La Nava Eva Maria; Mateo Herranz Ana Isabel; Parthasarathy Saravanan; Wang Xiaodong

Archive | 2015

ΕΝΩΣΕΙΣ ΚΑΙ ΜΕΘΟΔΟΙ ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΤΗΣ ΔΥΣΛΙΠΙΔΑΙΜΙΑΣ

Cao Guoqing; Escribano Ana Maria; Fernandez Maria Carmen; Fields Todd; Gernert Douglas Linn; Cioffi Christopher Lawrence; Herr Robert Jason; Mantlo Nathan Bryan; Martin De La Nava Eva Maria; Mateo-Herranz Ana Isabel; Mayhugh Daniel Ray; Wang Xiaodong

Archive | 2013

PROTEIN KINASE INHIBITORS, PHARMACEUTICAL COMPOSITION BASED THEREON AND THERAPEUTICAL USE

Coates David Andrew; De Dios Alfonso; De Prado Gonzales Ana; Del Prado Catalina Miriam Filadelfa; Garcia Paredes Maria Cristina; Gelbert Lawrence Mark; Knobeloch John Monte; Martin De La Nava Eva Maria; Martin Ortega Finger Maria Dolores; Martinez Perez Jose Antonio; Mateo Herranz Ana Isabel; Perez Martinez Carlos; Sanchez Martinez Concepcion

Archive | 2013

Compuestos derivados de 5-[5-(3,5-difluorofenil)-1h-imidazol-4-il][1,3]oxazolo[5,4-b]piridin-2-amina; composicion farmaceutica; combinacion farmaceutica; uso para el uso en tratamiento de cancer, tal como cancer de ovarios, mieloma multiple, entre otros

Coates David Andrew; Gilmour Raymond; Martin Jose Alfredo; Martin De La Nava Eva Maria

Archive | 2013

COMPUESTOS DE OXAZOL[5,4-B]PIRIDIN-5-ILO Y SU USO PARA EL TRATAMIENTO DEL CANCER

Coates David Andrew; Gilmour Raymond; Martin Jose Alfredo; Martin De La Nava Eva Maria

Archive | 2013

COMPUESTOS DE OXAZOL[5,4-b]PIRIDIN-5-ILO

Coates David Andrew; Gilmour Raymond; Martin Jose Alfredo; Martin De La Nava Eva Maria

Archive | 2012

Compounds comprising benzimidazolyl, pyrimidinyl, and pyridinyl moieties which are useful as protein kinase inhibitors

Coates David Andrew; De Dios Alfonso; De Prado Gonzales Ana; Del Prado Catalina Miriam Filadelfa; Garcia Paredes Maria Cristina; Gelbert Lawrence Mark; Knobeloch John Monte; Martin De La Nava Eva Maria; Martin Ortega Finger Maria Dolores; Martinez Perez Jose Antonio; Mateo Herranz Ana Isabel; Perez Martinez Carlos; Sanchez Martinez Concepcion

Archive | 2011

INHIBIDORES DE PROTEÍNA CINASA

Coates David Andrew; De Dios Alfonso; De Prado Gonzales Ana; Del Prado Catalina Miriam Filadelfa; Garcia Paredes Maria Cristina; Gelbert Lawrence Mark; Knobeloch John Monte; Martin De La Nava Eva Maria; Martin Ortega Finger Maria Dolores; Martinez Perez Jose Antonio; Mateo Herranz Ana Isabel; Perez Martinez Carlos; Sanchez Martinez Concepcion

Archive | 2009

VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON DYSLIPIDEMIE

Cao Guoqing; Escribano Ana Maria; Fernandez Maria Carmen; Fields Todd; Gernert Douglas Linn; Cioffi Christopher Lawrence; Herr Robert Jason; Mantlo Nathan Bryan; Martin De La Nava Eva Maria; Mateo Herranz Ana Isabel; Mayhugh Daniel Ray; Wang Xiaodong

Explore More

Collaboration

Dive into the Martin De La Nava Eva Maria's collaboration.

Top Co-Authors
Avatar

Mateo Herranz Ana Isabel

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Escribano Ana Maria

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Mantlo Nathan Bryan

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Fernandez Maria Carmen

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Wang Xiaodong

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Cao Guoqing

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Cioffi Christopher Lawrence

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Fields Todd

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Herr Robert Jason

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Mayhugh Daniel Ray

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge